CN Patent

CN102911169B — 一种卢拉西酮的制备方法

Assigned to Shanghai Institute of Pharmaceutical Industry · Expires 2015-05-06 · 11y expired

What this patent protects

本发明公开了一种如式I所示的卢拉西酮的制备方法，其包括下列步骤：在极性非质子溶剂中，在碱的作用下，将化合物II或化合物III，与化合物IV在50～150℃下进行如下反应，即可；本发明的卢拉西酮的制备方法收率高、操作简便、成本低，适合于工业上大规模生产，为卢拉西酮的制备提供了一条新的途径。

USPTO Abstract

本发明公开了一种如式I所示的卢拉西酮的制备方法，其包括下列步骤：在极性非质子溶剂中，在碱的作用下，将化合物II或化合物III，与化合物IV在50～150℃下进行如下反应，即可；本发明的卢拉西酮的制备方法收率高、操作简便、成本低，适合于工业上大规模生产，为卢拉西酮的制备提供了一条新的途径。

Drugs covered by this patent

lurasidone-hydrochloride (LURASIDONE HYDROCHLORIDE)

Patent Metadata

Patent number: CN102911169B
Jurisdiction: CN
Classification: —
Expires: 2015-05-06
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Institute of Pharmaceutical Industry
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.